These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8160589)

  • 1. Considerations for ventricular fibrillation detection by implantable cardioverter defibrillators.
    Jones GK; Bardy GH
    Am Heart J; 1994 Apr; 127(4 Pt 2):1107-10. PubMed ID: 8160589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tachycardia detection in modern implantable cardioverter-defibrillators.
    Brüggemann T; Dahlke D; Chebbo A; Neumann I
    Herzschrittmacherther Elektrophysiol; 2016 Sep; 27(3):171-85. PubMed ID: 27576695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective left ventricular sensing lead implantation to overcome undersensing of ventricular fibrillation during implantable cardioverter defibrillator implantation.
    Steinberg C; Philippon F; O'Hara G; Molin F
    Can J Cardiol; 2013 Jun; 29(6):751.e3-6. PubMed ID: 23395280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fully automatic, implantable cardioverter-defibrillator algorithm to prevent inappropriate detection of ventricular tachycardia or fibrillation due to T-wave oversensing in spontaneous rhythm.
    Cao J; Gillberg JM; Swerdlow CD
    Heart Rhythm; 2012 Apr; 9(4):522-30. PubMed ID: 22094074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable pacer-cardioverter-defibrillator induced episode types and programming strategies.
    Olson WH; Gunderson BD; Bardy GH
    J Electrocardiol; 1992; 25 Suppl():145. PubMed ID: 1297682
    [No Abstract]   [Full Text] [Related]  

  • 6. Inappropriate disabling of an ICD noise-detection algorithm in pacemaker-dependent patients.
    Welte N; Gang ES; Swerdlow CD; Strik M; Bordachar P; Ploux S
    Pacing Clin Electrophysiol; 2019 Apr; 42(4):478-482. PubMed ID: 30515880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of the algorithm to reconfirm ventricular fibrillation in a third-generation implantable cardioverter defibrillator.
    Mattke S; Kramm B
    Pacing Clin Electrophysiol; 1997 Apr; 20(4 Pt 1):993-4. PubMed ID: 9127409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Undersensing during ventricular tachyarrhythmias in a third-generation implantable cardioverter defibrillator: diagnosis using stored electrograms and correction with programming.
    Mann DE; Kelly PA; Damle RS; Reiter MJ
    Pacing Clin Electrophysiol; 1994 Sep; 17(9):1525-30. PubMed ID: 7991424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.
    Zareba W
    Cardiol J; 2009; 16(5):391-3. PubMed ID: 19753515
    [No Abstract]   [Full Text] [Related]  

  • 10. Causes of ventricular oversensing in implantable cardioverter-defibrillators: implications for diagnosis of lead fracture.
    Gunderson BD; Swerdlow CD; Wilcox JM; Hayman JE; Ousdigian KT; Ellenbogen KA
    Heart Rhythm; 2010 May; 7(5):626-33. PubMed ID: 20184977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter defribrillator shocks: a troubleshooting guide.
    Swerdlow CD; Zhang J
    Rev Cardiovasc Med; 2001; 2(2):61-72. PubMed ID: 12439383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice.
    Jodko Ł; Kornacewicz-Jach Z; Kaźmierczak J; Rzeuski R; Zielonka J; Kaliszczak R; Safranow K
    Cardiol J; 2009; 16(5):432-9. PubMed ID: 19753522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is inappropriate therapy a resolved issue with current implantable cardioverter defibrillators?
    Brugada J
    Am J Cardiol; 1999 Mar; 83(5B):40D-44D. PubMed ID: 10089838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of initial detection and redetection of ventricular fibrillation in a transvenous defibrillator system with automatic gain control.
    Berul CI; Callans DJ; Schwartzman DS; Preminger MW; Gottlieb CD; Marchlinski FE
    J Am Coll Cardiol; 1995 Feb; 25(2):431-6. PubMed ID: 7829798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technologic advances in implantable cardioverter defibrillators.
    Swygman CA; Homoud MK; Link MS; Wang PJ; Estes NA
    Curr Opin Cardiol; 1999 Jan; 14(1):9-14. PubMed ID: 9932202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal Implantable Cardioverter Defibrillator Programming.
    Shah BK
    Cardiol Rev; 2017; 25(1):30-35. PubMed ID: 27922468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter investigation of an implantable cardioverter-defibrillator algorithm to detect oversensing.
    Welte N; Strik M; Eschalier R; Mondoly P; Defaye P; Frontera A; Ritter P; Haïssaguerre M; Ploux S; Koneru J; Ellenbogen KA; Bordachar P
    Heart Rhythm; 2017 Jul; 14(7):1008-1015. PubMed ID: 28323174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensing and detection in Medtronic implantable cardioverter defibrillators.
    Brown ML; Swerdlow CD
    Herzschrittmacherther Elektrophysiol; 2016 Sep; 27(3):193-212. PubMed ID: 27624809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spurious redetection of sinus rhythm by an implantable cardioverter defibrillator during spontaneous ventricular fibrillation.
    Otto L; Mann DE; Kelly PA; Reiter MJ
    Pacing Clin Electrophysiol; 1999 Oct; 22(10):1550-2. PubMed ID: 10588160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive scheme for detection of ventricular fibrillation for implantable cardioverter defibrillators.
    Caswell SA; Jenkins JM; DiCarlo LA
    J Electrocardiol; 1998; 30 Suppl():131-6. PubMed ID: 9535490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.